Cilostazol for preventing brain injury after aneurysm bleeding
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether the drug cilostazol can prevent delayed brain damage in people who have had bleeding from a brain aneurysm. It is for adults who had their aneurysm treated within 72 hours and are in moderate to serious condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had bleeding around the brain from a confirmed aneurysm and it was treated with coiling or clipping within 72 hours.
- Your condition is rated Hunt-Hess grade II to IV (moderate to serious).
- No new bleeding was seen on a CT scan 6 hours after surgery.
- You do not have more than one aneurysm.
- You are not allergic to cilostazol, do not have severe heart failure, bleeding problems, or severe liver or kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a statin medication very early (within 6 hours of symptoms) can improve recovery after a brain aneurysm bleed. It aims to see if early treatment helps protect the brain.
This study tests whether starting blood pressure treatment soon after surgery or coiling for a brain aneurysm can improve recovery. It is for people who had a bleeding stroke from a ruptured aneurysm and are in the hospital for treatment.
This trial tests whether adding cilostazol to standard nimodipine treatment helps people recover better after a brain aneurysm bursts. Both drugs aim to prevent delayed complications from the bleeding.
This study tests if a medicine called tirofiban (which helps prevent blood clots) can improve recovery after a brain aneurysm rupture. It is for people who have had their aneurysm treated with a coil and are at risk of a delayed stroke.
This trial studies a spinal fluid (CSF) treatment to help prevent dangerous blood-vessel tightening (vasospasm) after a type of brain bleed caused by an aneurysm. If you qualify, the goal is to reduce complications soon after aneurysm repair.
This Phase 2 trial tests whether milrinone, a heart-acting medicine, can improve brain blood flow to help prevent delayed brain ischemia after a severe subarachnoid hemorrhage. It may help reduce later brain damage in people who are too ill or sedated for a normal neurologic exam early on.
Hear when a new Aneurysmal Subarachnoid Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.